- Curaleaf Holdings (CSE:CURA) has launched a second dispensary location in Sarasota, Florida, marking the 61st location in the state
- The new dispensary is open as of Friday and will be open seven days a week
- The second Sarasota dispensary will offer a curated menu of premium cannabis products
- Shares of Curaleaf Holdings are down 0.43 per cent to C$4.68 as of 10:58 am ET
Curaleaf Holdings (CSE:CURA) continues to expand its presence in Florida.
The company announced on Friday the launch of its second dispensary location in Sarasota, Florida, marking the 61st location in the state.
Open as of Dec. 1, the new dispensary will offer a curated menu of premium cannabis products, including a selection of flower and pre-rolls, JAMS and Blu Kudu edibles and its top-selling Select Line products. Select Line ranges from Select Briq, Select Live Rosin and Select Live Rosin X Bites to the Cliq by Select vape hardware.
“Florida is an important market for us, and Sarasota is a vibrant, populous community that has welcomed Curaleaf with open arms since we launched our first medical dispensary in the area in 2019,” Matt Darin, CEO of Curaleaf Holdings, said in a statement. “We are thrilled to open a second location in this beautiful city to further expand access to the highest quality cannabis on the market, grow our business and build a deeper connection with the people of Sarasota.”
Curaleaf Holdings’ customers in Florida can also access its revamped rewards program that allows them to earn loyalty points for every dollar spent. These rewards can ue used for savings on future purchases at any Curaleaf Holdings dispensary.
With its headquarters out of New York City, Curaleaf Holdings provides cannabis consumer products under its Curaleaf, Select and Grassroots brands. These brands are sold in 17 states across 147 dispensaries.
Shares of Curaleaf Holdings are down 0.43 per cent to C$4.68 as of 10:58 am ET.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.